Geron
在场
高管
查看带有其 22 名主要高管的组织结构图
Geron 搜索最多的简介
- John Scarlett, Chief Executive Officer and Chairman of the Board
- Robert Spiegel, Director
- Gaurav Aggarwal, Director
高管在Geron变化
- Gaurav Aggarwal已作为Director加入公司 (新闻发布的2023十一月29号).
- Michelle Robertson已作为Executive Vice President, Chief Financial Officer and Treasurer加入公司 (新闻发布的2023九月12号).
- Olivia Bloom, Executive Vice President, Finance, Chief Financial Officer and Treasurer, 正在办理退休 (新闻发布的2023九月12号).
创建提醒
跟踪 Geron 的高管变动
生物技术
Geron 拥有 2,289 家竞争者，其中包括 Lonza (瑞士)、Eurofins (卢森堡) 和 Adaptive Phage Therapeutics (美国(美洲))。
Popular M&A news in 生物技术
- Delphia Therapeutics 刚刚宣布为 67 筹款数百万美元。 (公布2024五月7号).
- Karius 刚刚宣布为 100 筹款数百万美元。 (公布2024五月3号).
- Transcarent 刚刚宣布为 126 筹款数百万美元。 (公布2024五月2号).
生物技术 行业的其他推荐联系人
消息
Geron 的最新新闻稿
- Geron Corporation Announces Pricing of $150 Million Underwritten Offering of Common Stock and Pre-Funded Warrants
- Geron Announces FDA Oncologic Drugs Advisory Committee Votes in Favor of the Clinical Benefit/Risk Profile of Imetelstat for the Treatment of Transfusion-Dependent Anemia in Patients with Lower-Risk MDS
- Geron Corporation Reports Business Highlights and Fourth Quarter and Full Year 2023 Financial Results
- Geron Announces PDUFA Date for Imetelstat NDA in Lower Risk MDS
- Geron Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- Geron Announces FDA Acceptance of New Drug Application for Imetelstat for the Treatment of Lower Risk MDS
- Geron Corporation Reports Business Highlights and Second Quarter 2023 Financial Results
- Geron to Announce Second Quarter 2023 Financial Results on August 3, 2023
- Geron Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- Geron Announces U.S. Expanded Access Protocol for Imetelstat in Lower Risk MDS
- View more press releases Close
通过电子邮件
